Manufacturer record
Avalon Medicines Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Avalon Medicines Pvt. Ltd (Haryana) were declared Not of Standard Quality between December 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AMT-2460, Telmisartan & Hydrochlorothiazide Tablets IP (exp Oct 2027). CDTL, Hyderabad (CDSCO lab) found it not of standard quality: The sample received does not conform to i.p. 2022 specification with respect to the test for Dissolution of hydrochlorothiazide only. Listed in the July 2026 alert.
Records by type
6 records linked to Avalon Medicines Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan & Hydrochlorothiazide Tablets IP | Batch AMT-2460Mfg Nov 2025 · Exp Oct 2027 | The sample received does not conform to i.p. 2022 specification with respect to the test for Dissolution of hydrochlorothiazide only.Dissolution | CDTL, HyderabadCDSCO lab | Jul 2026 |
| Nexicold Total | Batch AMT-1925Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to the tests Description and Disintegration of Tablets. Also, the colour is not mentioned on the label which is violation of Rule 127(2) of Drug Rules, 1945.Description | MDTL KathuaState lab | Jun 2026 |
| Glimepiride Tablets IP | Batch AMT-2153Mfg Sep 2025 · Exp Aug 2027 | The sample fails the test 'Dissolution' as per IPDissolution | DTL ThiruvananthapuramState lab | Apr 2026 |
| Paracetamol, Levocetirizine Hydrochloride & Phenyleprine Hydrochloride Tablets | Batch AMT-0309Mfg Apr 2024 · Exp Mar 2026 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Paracetamol Phenylephrine HCl, Diphenh | Batch ANT-1925Mfg Jul 2025 · Exp Jun 2027 | DescriptionDescription | FDTL,UttarakhandState lab | Feb 2026 |
| Pantoremed-40 Tables | Batch AMT-0892AMfg Oct 2024 · Exp Sep 2026 | The sample does not comply with IP requrements for Dissolution Test at Acid StageDissolution | FDAL, MumbaiState lab | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.